SNCA and synucleinopathy: To determine whether our reformulated α-synuclein assays address this gap, we first performed bilateral striatal injections of mouse α-synuclein PFFs (5 μg/hemisphere) in WT mice to induce significant synucleinopathy, with corresponding PBS-injected mice (sham) serving as controls.